Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer
Cannabis Law Report
JUNE 25, 2021
Professor David Nutt commented, “I am delighted to take on the role of Chief Research Officer in this exciting new biotechnology company that promises to revolutionise the treatment of addictions. Awakn’s combination of pre-clinical and clinical research uniquely positions Awakn to solve some of the biggest societal problems.”.
Let's personalize your content